Literature DB >> 22530735

Microscopic rearrangement of bound minor groove binders detected by NMR.

Michael Rettig1, Markus W Germann, Mohamed A Ismail, Adalgisa Batista-Parra, Manoj Munde, David W Boykin, W David Wilson.   

Abstract

Thermodynamic and structural studies are commonly utilized to optimize small molecules for specific DNA interactions, and, thus, a significant amount of binding data is available. However, the dynamic processes that are involved in minor groove complex formation and maintenance are not fully understood. To help define the processes involved, we have conducted 1D and 2D NMR in conjunction with biosensor-SPR experiments with a variety of compounds and symmetric, as well as asymmetric, AT tract DNA sequences. Surprisingly, the NMR data clearly show exchange between equivalent binding sites for strongly binding compounds like netropsin and DB921 (Ka > 10(8) M(-1)) that does not involve dissociation off the DNA. A quantitative analysis of the data revealed that these bound exchange rates are indeed much faster than the macroscopic dissociation rates which were independently determined by biosensor-SPR. Additionally, we could show the existence of at least two 1:1 compound DNA complexes at the same site for the interaction of these compounds with an asymmetric DNA sequence. To explain this behavior we introduced a model in which the ligand is rapidly flipping between two orientations while in close association with the DNA. The ligand reorientation will contribute favorably to the binding entropy. As the potential of minor groove binders to form more than a single complex with asymmetric, as well as symmetric, duplexes is widely unknown, the consequences for binding thermodynamics and compound design are discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22530735      PMCID: PMC3637426          DOI: 10.1021/jp301143e

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  39 in total

Review 1.  New approaches toward recognition of nucleic acid triple helices.

Authors:  Dev P Arya
Journal:  Acc Chem Res       Date:  2010-11-12       Impact factor: 22.384

2.  Dynamics and binding mode of Hoechst 33258 to d(GTGGAATTCCAC)2 in the 1:1 solution complex as determined by two-dimensional 1H NMR.

Authors:  A Fede; A Labhardt; W Bannwarth; W Leupin
Journal:  Biochemistry       Date:  1991-12-03       Impact factor: 3.162

Review 3.  Transforming ligands into transcriptional regulators: building blocks for bifunctional molecules.

Authors:  Jonas W Højfeldt; Aaron R Van Dyke; Anna K Mapp
Journal:  Chem Soc Rev       Date:  2011-06-23       Impact factor: 54.564

4.  Telomere targeting with a new G4 ligand enhances radiation-induced killing of human glioblastoma cells.

Authors:  Patrick Merle; Bertrand Evrard; Anne Petitjean; Jean-Marie Lehn; Marie-Paule Teulade-Fichou; Emmanuel Chautard; Anne De Cian; Lionel Guittat; Phong Lan Thao Tran; Jean-Louis Mergny; Pierre Verrelle; Andreï Tchirkov
Journal:  Mol Cancer Ther       Date:  2011-10       Impact factor: 6.261

Review 5.  Riboswitches: discovery of drugs that target bacterial gene-regulatory RNAs.

Authors:  Katherine E Deigan; Adrian R Ferré-D'Amaré
Journal:  Acc Chem Res       Date:  2011-05-26       Impact factor: 22.384

6.  DNA sequence-specific polyamides alleviate transcription inhibition associated with long GAA.TTC repeats in Friedreich's ataxia.

Authors:  Ryan Burnett; Christian Melander; James W Puckett; Leslie S Son; Robert D Wells; Peter B Dervan; Joel M Gottesfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-20       Impact factor: 11.205

7.  SG2285, a novel C2-aryl-substituted pyrrolobenzodiazepine dimer prodrug that cross-links DNA and exerts highly potent antitumor activity.

Authors:  John A Hartley; Anzu Hamaguchi; Marissa Coffils; Christopher R H Martin; Marie Suggitt; Zhizhi Chen; Stephen J Gregson; Luke A Masterson; Arnaud C Tiberghien; Janet M Hartley; Christopher Pepper; Thet Thet Lin; Christopher Fegan; David E Thurston; Philip W Howard
Journal:  Cancer Res       Date:  2010-07-26       Impact factor: 12.701

8.  Solvation dynamics of Hoechst 33258 in water: an equilibrium and nonequilibrium molecular dynamics study.

Authors:  Kristina E Furse; Beth A Lindquist; Steven A Corcelli
Journal:  J Phys Chem B       Date:  2008-02-14       Impact factor: 2.991

9.  Binding of an antitumor drug to DNA, Netropsin and C-G-C-G-A-A-T-T-BrC-G-C-G.

Authors:  M L Kopka; C Yoon; D Goodsell; P Pjura; R E Dickerson
Journal:  J Mol Biol       Date:  1985-06-25       Impact factor: 5.469

Review 10.  Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?

Authors:  Shankar Balasubramanian; Laurence H Hurley; Stephen Neidle
Journal:  Nat Rev Drug Discov       Date:  2011-04       Impact factor: 84.694

View more
  5 in total

1.  Small-molecule binding to the DNA minor groove is mediated by a conserved water cluster.

Authors:  DengGuo Wei; W David Wilson; Stephen Neidle
Journal:  J Am Chem Soc       Date:  2013-01-16       Impact factor: 15.419

2.  Molecular basis for sequence-dependent induced DNA bending.

Authors:  Michael Rettig; Markus W Germann; Shuo Wang; W David Wilson
Journal:  Chembiochem       Date:  2013-01-25       Impact factor: 3.164

3.  Bound Compound, Interfacial Water, and Phenyl Ring Rotation Dynamics of a Compound in the DNA Minor Groove.

Authors:  Narinder K Harika; W David Wilson
Journal:  Biochemistry       Date:  2018-08-09       Impact factor: 3.162

4.  A short DNA sequence confers strong bleomycin binding to hairpin DNAs.

Authors:  Chenhong Tang; Ananya Paul; Mohammad P Alam; Basab Roy; W David Wilson; Sidney M Hecht
Journal:  J Am Chem Soc       Date:  2014-09-22       Impact factor: 15.419

5.  Imino proton NMR guides the reprogramming of A•T specific minor groove binders for mixed base pair recognition.

Authors:  Narinder K Harika; Ananya Paul; Ekaterina Stroeva; Yun Chai; David W Boykin; Markus W Germann; W David Wilson
Journal:  Nucleic Acids Res       Date:  2016-04-29       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.